Archives

+

Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting

April 3, 2024|Media, News | 1 Min Read

Pleural tuberculosis (TB) remains difficult to diagnose. Tests measuring host biomarkers, such as adenosine deaminase (ADA) and unstimulated interferon-gamma, perform better than conventional microbiological tests for TB diagnosis using pleural […]

Read More
+

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study

March 29, 2024|Media, News | 1 Min Read

The diagnosis of pleural tuberculosis (TB) is problematic. The comparative performance of newer same-day tools for pleural TB, including Xpert MTB/RIF Ultra (ULTRA), has hitherto not been comprehensively studied. Adenosine […]

Read More
+

Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: A prospective cohort study

March 17, 2024|Media, News | 1 Min Read

The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection. The usefulness […]

Read More
+

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting

March 11, 2024|Media, News | 1 Min Read

Tuberculous pericarditis (TBP) is associated with high morbidity and mortality and is an important treatable cause of heart failure in developing countries. Tuberculous etiology of pericarditis is difficult to diagnose […]

Read More
+

Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis

February 12, 2024|Media, News | 1 Min Read

The rapid diagnosis of tuberculous meningitis (TBM) is problematic. We found in 150 patients with suspected TBM that, similar to RD-1-specific quantitative cerebrospinal fluid (CSF) T-cell responses, unstimulated CSF gamma […]

Read More
+

Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis

January 3, 2024|Media, News | 1 Min Read

We compared the diagnostic utility of unstimulated pleural IFN-γ levels with several pleural antigen-specific T-cell IGRAs (early secretory antigenic target-6 and culture filtrate protein-10 (T-SPOT.®TB, QuantiFERON®-TB Gold In-tube), purified protein […]

Read More
+

Press Release

December 21, 2018|Media, News | 2 Min Read

Project Overview Antrum Biotech, a healthcare innovations company dedicated to acquiring, developing and commercialising novel diagnostic platforms for infectious diseases, announces the launch of IRISATM-TB, an immuno-suspension assay for diagnosis […]

Read More
Rapid diagnosis of TB meningitis is imperative and a biomarker-based test is needed: We need to move beyond detecting the bacilli to combat TBM mortality!
+

Rapid diagnosis of TB meningitis is imperative and a biomarker-based test is needed: We need to move beyond detecting the bacilli to combat TBM mortality!

December 12, 2018|Media, News | 3 Min Read

Background CNS infections are a leading cause of HIV-related deaths in sub-Saharan Africa, but causes and outcomes are poorly defined. We aimed to determine mortality and predictors of mortality in […]

Read More
+

New rapid TB test developed

August 21, 2018|Media, News | 3 Min Read

TB is the most common cause of death in South Africa Researchers at the University of Cape Town have developed a landmark new rapid test which diagnoses various forms of Tuberculosis (TB) within hours. […]

Read More
Antrum Biotech
+

New TB meningitis test beats the rest

July 17, 2018|Media, News | 4 Min Read

TB meningitis is a major cause of death in Southern Africa. Early diagnosis is the key to improving the health outcomes of this disease, but the current diagnostic tests are […]

Read More